Marc Beer contribution to development of pharmaceutical industry

Marc Beer is an experienced business person with more than 25 years of running business and leadership. He is a significant play in innovative products and services in the pharmaceutical industry. Marc founded Renovia in August of 2016 whose primary focus was to offer modern treatment and diagnosis to millions of women suffering from pelvic disorders. The company combines digital health and cutting-edge sensor technologies to provide services to its clients.

Before starting Renovia, Marc beer worked as Chief Executive Officer at ViaCell a well-established biotechnology.The company deals with blood stem cells research. While at the ViaCell, the company experienced tremendous growth in its operations and revenue.

Marc Beer while serving as the CEO of ViaCell, he was in the management board of Erytech Pharma, a leading bio pharmaceutical firm .In addition Marc significantly helped in pioneering the global commercialization and development of medical products that treat rare diseases while serving as the Vice President of Global Marketing.

Beer is credited as founding chairman of Minerva Neurosciences Inc, Minerva is a clinical-stage biopharmaceutical company that develops products to treat central nervous system diseases.

Marc Beer accomplishment as seen him appointed, as the chairman of the board of LumeNXT Inc. LumeNX which is a privately owned company focus on the development of an efficient surgical illumination product line for minimally invasive surgeries. Marc brings on board his many years of achievement of development and commercialization in pharmaceuticals, devices, diagnostics, and biotechnology. Speaking during the appointment, Mark Beer expressed his appreciation for the new role and opportunity to work with a team of engineers and surgeons at LumeNXT.He applauds the steps that LumeN XT has achieved in developing proprietary technology in doing surgery. ,” said Marc Beer “I believe the importance of the LumeN XT platform will expand as more surgeries will be done with minimally invasive approaches.

 

Paul Rhyne, Co-Founder of LumeN XT, said that Marc has demonstrated a high level of success in the multiple starts up that he has a guide from small companies to big multinationals. Rhyne noted that Beer would be of great value to the company as the company undertakes massive growth in the medical field. Learn more: https://www.crunchbase.com/person/marc-beer

 

Leave a Reply

Your email address will not be published. Required fields are marked *